Osteoboost key facts
as of Oct 2026- Developer of a medical device designed to provide relief from osteopenia.
- Osteoboost is valued at approximately $45.0M as of Oct 2026, set at its later-stage round, Apr 2026; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $17.8M across 1 recorded rounds; the latest was Accelerator/Incubator in Jan 2024.
- Notable investors include MedTech Innovator, Springboard Enterprises, Matter (Consulting Services (B2B)), Band of Angels, Good Growth Capital — 20 tracked in total.
- 1 investment vehicle was formed to buy Osteoboost shares in the last 12 months, reporting $600K sold to 10 investors, per SEC Form D filings.
- Status: Privately Held (backing).
Valued at $45.0M at its later-stage round, Apr 2026. Nothing has traded since.
- ·The complete investor list: 20 names
- ·Watch Osteoboost: the Monday email on marks, rounds and moves
Osteoboost funding rounds
1 roundsVehicles formed to buy Osteoboost shares
secondary demand · SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy Osteoboost shares, reporting $600K sold to 10 investors. Most recent filing May 2026.
Membership and data by Private Market View
Who backs Osteoboost
20+Osteoboost valuation
Osteoboost was valued at $45 million at its later-stage round in Apr 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Osteoboost raised?
Osteoboost has raised $17.8 million in total; 1 of its rounds is on record. The most recent was an accelerator round in Jan 2024.
Institutional holders and vehicles
In the last 12 months, 1 investment vehicle was formed to buy Osteoboost shares, reporting $600,000 sold to 10 investors, per SEC Form D filings (most recent May 2026).
Osteoboost investors
20 investors are on record for Osteoboost, including MedTech Innovator, Springboard Enterprises, Matter (Consulting Services (B2B)) and Band of Angels.
Comparable companies
Comparable therapeutic devices names by valuation on PrivateMarketView: Materna Medical ($110 million), Luminate Medical ($74.5 million) and NasaClip ($16 million).
About Osteoboost
Developer of a medical device designed to provide relief from osteopenia. The company offers precise, sensor-calibrated vibration delivery, integrated tracking and reminders, and at-home usability to slow bone density loss in postmenopausal women with osteopenia through a wearable vibration therapy device, enabling patients suffering from bone mass problems to access an effective non-drug intervention.
- Industry
- Therapeutic Devices
- Sector
- Healthcare
- HQ
- Redwood City, CA, United States
- Founded
- 2014
- Employees
- 12
- Website
- osteoboost.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.